表紙
市場調查報告書

HIV、AIDS檢驗的全球市場:2019年∼2023年

HIV-AIDS Testing Market by End-users and Geography - Global Forecast and Analysis 2019-2023

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 910742
出版日期 內容資訊 英文 144 Pages
訂單完成後即時交付
價格
Back to Top
HIV、AIDS檢驗的全球市場:2019年∼2023年 HIV-AIDS Testing Market by End-users and Geography - Global Forecast and Analysis 2019-2023
出版日期: 2019年09月11日內容資訊: 英文 144 Pages
簡介

全球HIV、AIDS檢驗市場上,HIV感染的盛行率增加,HIV感染的早期發現的認識高漲,有關HIV研究的政府輔助,HIV檢驗的有益推薦事項等成為成長促進因素,在預測期間內預計將以10%以上的年複合成長率擴大。但,HIV毒株的地區性多樣性阻礙診斷能力,發展途中地區有限的基礎建設,臨床性HIV檢驗相關的社會歧視眼光及道德性影響等要素,可能妨礙在預測期間內HIV、AIDS檢驗產業的成長。

本報告提供全球HIV、AIDS檢驗市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2018年)
  • 市場規模及預測(2018年∼2023年)

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各終端用戶

  • 市場區隔:各終端用戶
  • 各終端用戶比較:市場規模及預測(2018年∼2023年)
  • 診斷研究所
  • 醫院
  • 其他
  • 市場機會:各終端用戶

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2018年∼2023年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • POC試驗產品的採用增加
  • 第4代試驗產品的存取擴大
  • HIV檢驗價格低

第12章 業者情勢

  • 概要
  • 創造性破壞狀況

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott Laboratories
  • Becton Dickinson and Co.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • OraSure Technologies Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Siemens Healthineers AG

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR32016

About this market

Technavio's HIV-AIDS testing market analysis considers sales from diagnostic laboratories, hospitals, and other end-users. Our analysis also considers the sales of HIV-AIDS testing in Asia, Europe, North America, and ROW. In 2018, the diagnostic laboratories segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increasing investments in the development of HIV testing laboratory infrastructure will play a significant role in the diagnostic laboratories segment to maintain its market position. Also, our global HIV-AIDS testing market report looks at factors such as the increasing prevalence of HIV infections, growing awareness for early detection of HIV infection, and government support for HIV research and favorable recommendations on HIV testing. However, regional diversity in HIV strains hampers diagnostic capabilities, limited infrastructure in developing regions, and social stigma and ethical implication associated to clinical HIV testing may hamper the growth of the HIV-AIDS testing industry over the forecast period.

Overview

Government support for HIV research and favorable recommendations on HIV testing

The significant burden of HIV-AIDS has been a major concern for governments worldwide. To reduce the spread of HIV infections, governments are focusing on establishing efficient healthcare infrastructure for timely detection and treatment of HIV infections. Government allocates significant resources to increase the reach of HIV-AIDS programs and services. Federal funding is provided through direct grants, cooperative agreements, and contracts to support HIV awareness, treatment, and prevention. Such growth in funding helped promote the development of advanced HIV-AIDS testing products and increase the adoption of HIV-AIDS testing products among individuals in respective regions. Also, favorable recommendations by government authorities such as the CDC have surged the adoption of routine HIV-AIDS testing among adults, adolescents, and pregnant women. Such factors will lead to the expansion of the global HIV-AIDS testing market at a CAGR of over 10% during the forecast period.

Growing access to fourth-generation testing products

The commercial availability of fourth-generation tests for HIV has been a result of continuous efforts by market vendors in the development of advanced and early detection technologies for HIV testing. The detection of both antibodies and antigen allows fourth-generation tests to identify the presence of HIV infection sooner and with greater accuracy than conventional processes. The windows period of fourth-generation test is about 25% shorter than the third-generation HIV tests and about 50% shorter than the second-generation HIV tests. This allows healthcare providers and clinicians to offer early and timely treatments to slow down the further progression of the disease. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global HIV-AIDS testing market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of a few major players, the global HIV-AIDS testing market is concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading HIV-AIDS testing manufacturers, that include Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, and Siemens Healthineers AG.

Also, the HIV-AIDS testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Diagnostic laboratories - Market size and forecast 2018-2023
  • Hospitals - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing adoption of POC testing products
  • Growing access to fourth-generation testing products
  • Decreasing prices of HIV tests

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • Becton Dickinson and Co.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • OraSure Technologies Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Siemens Healthineers AG

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Product overview
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: End-user - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by end-user
  • Exhibit 20: Diagnostic laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Diagnostic laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Hospitals - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Hospitals - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: Others - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Market opportunity by end-user
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2018-2023 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 34: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 35: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 36: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 37: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 38: Key leading countries
  • Exhibit 39: Market opportunity
  • Exhibit 40: Impact of drivers and challenges
  • Exhibit 41: Vendor landscape
  • Exhibit 42: Landscape disruption
  • Exhibit 43: Vendors covered
  • Exhibit 44: Vendor classification
  • Exhibit 45: Market positioning of vendors
  • Exhibit 46: Abbott Laboratories - Vendor overview
  • Exhibit 47: Abbott Laboratories - Business segments
  • Exhibit 48: Abbott Laboratories - Organizational developments
  • Exhibit 49: Abbott Laboratories - Geographic focus
  • Exhibit 50: Abbott Laboratories - Segment focus
  • Exhibit 51: Abbott Laboratories - Key offerings
  • Exhibit 52: Becton Dickinson and Co. - Vendor overview
  • Exhibit 53: Becton Dickinson and Co. - Business segments
  • Exhibit 54: Becton Dickinson and Co. - Organizational developments
  • Exhibit 55: Becton Dickinson and Co. - Geographic focus
  • Exhibit 56: Becton Dickinson and Co. - Segment focus
  • Exhibit 57: Becton Dickinson and Co. - Key offerings
  • Exhibit 58: bioMerieux SA - Vendor overview
  • Exhibit 59: bioMerieux SA - Business segments
  • Exhibit 60: bioMerieux SA - Organizational developments
  • Exhibit 61: bioMerieux SA - Geographic focus
  • Exhibit 62: bioMerieux SA - Key offerings
  • Exhibit 63: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 64: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 65: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 66: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 67: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 68: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 69: Danaher Corp. - Vendor overview
  • Exhibit 70: Danaher Corp. - Business segments
  • Exhibit 71: Danaher Corp. - Organizational developments
  • Exhibit 72: Danaher Corp. - Geographic focus
  • Exhibit 73: Danaher Corp. - Segment focus
  • Exhibit 74: Danaher Corp. - Key offerings
  • Exhibit 75: F. Hoffmann-La Roche Ltd. - Vendor overview
  • Exhibit 76: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 77: F. Hoffmann-La Roche Ltd. - Organizational developments
  • Exhibit 78: F. Hoffmann-La Roche Ltd. - Geographic focus
  • Exhibit 79: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibit 80: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 81: OraSure Technologies Inc. - Vendor overview
  • Exhibit 82: OraSure Technologies Inc. - Business segments
  • Exhibit 83: OraSure Technologies Inc. - Organizational developments
  • Exhibit 84: OraSure Technologies Inc. - Geographic focus
  • Exhibit 85: OraSure Technologies Inc. - Segment focus
  • Exhibit 86: OraSure Technologies Inc. - Key offerings
  • Exhibit 87: PerkinElmer Inc. - Vendor overview
  • Exhibit 88: PerkinElmer Inc. - Business segments
  • Exhibit 89: PerkinElmer Inc. - Organizational developments
  • Exhibit 90: PerkinElmer Inc. - Geographic focus
  • Exhibit 91: PerkinElmer Inc. - Segment focus
  • Exhibit 92: PerkinElmer Inc. - Key offerings
  • Exhibit 93: QIAGEN NV - Vendor overview
  • Exhibit 94: QIAGEN NV - Product segments
  • Exhibit 95: QIAGEN NV - Organizational developments
  • Exhibit 96: QIAGEN NV - Geographic focus
  • Exhibit 97: QIAGEN NV - Segment focus
  • Exhibit 98: QIAGEN NV - Key offerings
  • Exhibit 99: Siemens Healthineers AG - Vendor overview
  • Exhibit 100: Siemens Healthineers AG - Business segments
  • Exhibit 101: Siemens Healthineers AG - Organizational developments
  • Exhibit 102: Siemens Healthineers AG - Geographic focus
  • Exhibit 103: Siemens Healthineers AG - Segment focus
  • Exhibit 104: Siemens Healthineers AG - Key offerings
  • Exhibit 105: Validation techniques employed for market sizing
  • Exhibit 106: Definition of market positioning of vendors
Back to Top